HTA Database - Search Results

Sort by Relevance

Search Results [884 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Newborn screening for spinal muscular atrophy (SMA)]
2020	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Clinical effectiveness of pulse oximetry for neonatal screening of critical congenital heart diseases]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Testicular cancer: does regular screening for men from the age of 16 lead to better treatment outcomes?]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Prostate cancer screening with the PSA test]
2020	National Committee for Technology Incorporation (CONITEC)	[Newborn screening for congenital toxoplasmosis]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Lung cancer screening using low-dose computed tomography]
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Comparative results of the different screening strategies used for T21, T18 and T13: adaptation of the EUnetHTA assessment]
2020	Scottish Health Technologies Group (SHTG)	Second-generation colon capsule endoscopy (CCE-2) for the detection of colorectal polyps – SHTG Recommendation
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Digital tomosynthesis for breast cancer]
2020	Health Information and Quality Authority (HIQA)	Evidence summary for non-contact thermal screening as an effective means of identifying cases of COVID-19
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Virtual colonoscopy for colorectal cancer screening in patients with diverticular disease]
2020	NIHR Health Technology Assessment programme	Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT
2020	Andalusian Health Technology Assessment Area (AETSA)	Genetic risk prediction test for cardiovascular disease
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical Efectiveness of Newborn Screening for Inborn Errors of Metabolism by MS/ MS. Update and pilot study assessment: Maple Syrup Urine Disease; Isovaleric Acidaemia; Homocystinuria]
2020	European Network for Health Technology Assessment (EUnetHTA)	Lung cancer screening in risk groups
2020	Norwegian Institute of Public Health (NIPH)	Abdominal aorta aneurysm (AAA) screening of men aged 65
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Screening and testing for COVID-19 before surgery
2020	Swiss Federal Office of Public Health (FOPH)	Vitamin D testing
2020	Austrian Institute for Health Technology Assessment (AIHTA)	[Lung cancer screening in risk groups]
2020	Canary Health Service	[Cost-effectiveness analysis of newborn screening for severe combined immunodeficiency]
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Lung cancer screening in risk groups: a review-update of the economic evidence (Part II)
2020	Basque Office for Health Technology Assessment (OSTEBA)	[Neonatal hearing screening programmes: A systematic review of economic evaluation studies and descriptive analysis of Spanish regional programmes]
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	HPV testing for primary cervical cancer screening: a health technology assessment
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: breast tomosynthesis and breast cancer screening]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening for Diabetes mellitus: guideline recommendations
2019	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Evidence on the personalization of population-based breast cancer screening]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening programs for children and adolescents from 6 to 18 years. Results on selected countries, Austrian screening programmes and recommendations from evidence-based guidelines
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Cervical Carcinoma Prevention - Implementation of an HPV screening test for early detection of cervical cancer in Austria
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of the relevance of newborn blood spot screening for biotinidase deficiency (BIOT)]
2019	Health Information and Quality Authority (HIQA)	Systematic review of nutritional screening tools for adult patients in acute hospital settings. Nutrition screening and use of oral nutrition support for adults in the acute care setting
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of low-dose computed tomography lung cancer screening]
2019	NIHR Public Health Research (PHR) programme	How can interventions integrating health and academic education in schools help prevent substance misuse and violence, and reduce health inequalities among young people? Systematic review and evidence synthesis
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Newborn screening for sickle cell disease]
2019	Health Sciences Institute in Aragon (IACS)	Detection of diabetes' complications. Diabetic retinopathy. Economic evaluation of ultra-wide field scanning laser
2019	European Network for Health Technology Assessment (EUnetHTA)	Stool DNA testing for early detection of colorectal cancer
2019	European Network for Health Technology Assessment (EUnetHTA)	Screening for osteoporosis in the general population
2018	Canary Health Service	[SEEKER System for the screening of lysosomal storage diseases]
2018	NIHR Health Technology Assessment programme	Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of the prostate-specific antigen (PSA) test in prostate cancer screening in Québec]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for depression]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vitamin D - population screening and supplementation in populations with deficit]
2018	Norwegian Institute of Public Health (NIPH)	Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for hepatitis B]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for hepatitis C]
2018	NIHR Health Technology Assessment programme	Screening women aged 65 years or over for abdominal aortic aneurysm: a modelling study and health economic evaluation
2018	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Re-orientation of the Austrian parent-child preventive care programme. Part XI: Further development of the mother-child-pass: Screening recommendations of the expert working group for pregnancy, puerperium and early childhood (0-6 years)
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for serological group B streptococci within the framework of the medical check-ups according to the maternity Guidelines]
2018	Andalusian Health Technology Assessment Area (AETSA)	[Digital tomosynthesis in breast cancer: meta-analysis]
2018	NIHR Health Technology Assessment programme	UK Lung Cancer Screening Trial (UKLS) - Feasibility study and protocol development
2018	NIHR Health Technology Assessment programme	What works to Increase attendance for Diabetic Retinopathy screening? An Evidence sYnthEsiS (WIDeR-EyeS)
2018	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for severe combined immunodeficiency]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Invitation and decision aid for cervical cancer screening]
2018	Basque Office for Health Technology Assessment (OSTEBA)	[Immunological faecal occult blood test for patients with symptoms compatible with colorectal cancer: recommendation of Clinical Practice Guides and use in the National Health System]
2018	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening for chlamydia trachomatis and neisseria gonorrhoeae during pregnancy: a health technology assessment
2018	NIHR Health Technology Assessment programme	What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis
2018	NIHR Health Technology Assessment programme	Screening women aged 65 years or over for abdominal aortic aneurysm: a modelling study and health economic evaluation
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Colorectal cancer screening in persons with a relevant family history - Update to commission S11-01]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: comparison of cervical cancer screening strategies involving the human papillomavirus screening test (HPV test) or gynecological cytology (Pap test)]
2017	Norwegian Institute of Public Health (NIPH)	Digital Breast Tomosynthesis with Hologic 3D mammography Selenia Dimensions System for use in breast cancer screening
2017	Andalusian Health Technology Assessment Area (AETSA)	[Neonatal hypoacusis screening]
2017	NIHR Health Technology Assessment programme	Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis
2017	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Invitation and decision guide for breast cancer screening]
2017	Health Information and Quality Authority (HIQA)	Health technology assessment of human papillomavirus testing as the primary screening method for prevention of cervical cancer
2017	NIHR Health Technology Assessment programme	Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project
2017	Andalusian Health Technology Assessment Area (AETSA)	Multitarget stool DNA testing for colorectal cancer screening.
2017	NIHR Health Technology Assessment programme	Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
2017	Canary Health Service	[Early detection of hepatocarcinoma in patients at risk]
2017	NIHR Health Technology Assessment programme	Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project
2017	NIHR Health Services and Delivery Research programme	Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial: a three-armed randomised controlled trial of financial incentives
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening for hepatitis C virus: a systematic review
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Parent information on newborn screening using pulse oximetry; addendum to commission S13-01]
2016	NIHR Health Technology Assessment programme	A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo Danish Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Newborn screening for tyrosinaemia type 1 using tandem mass spectrometry]
2016	HAYES, Inc.	Epi proColon (Epigenomics Inc.)
2016	NIHR Health Technology Assessment programme	Enhanced invitation methods and uptake of health checks in primary care: randomised controlled trial and cohort study using electronic health records
2016	NIHR Health Technology Assessment programme	A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Information for health insurance fund members on ultrasound screening for abdominal aortic aneurysms: addendum to commission S13-04]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for asymptomatic bacteriuria within the framework of the German maternity guidelines, under special consideration of test methods - Addendum to Commission S13-02]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Invitation and decision aid for bowel cancer screening]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Newborn screening for severe combined immunodeficiency (SCID screening)]
2016	Health Sciences Institute in Aragon (IACS)	Effectiveness, security and economic evaluation of existing alternatives for monitoring growth and pubertal development
2016	Health Sciences Institute in Aragon (IACS)	Effectiveness, safety and economic evaluation of existing alternatives for the early detection of childhood hearing impairment
2016	Health Sciences Institute in Aragon (IACS)	Effectiveness, safety and economic evaluation of existing alternatives for the early detection of visual impairment in the paediatric population.
2016	NIHR Health Technology Assessment programme	The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation
2016	Institute of Health Economics (IHE)	Newborn blood spot screening for galactosemia, tyrosiemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease and severe combined immunodeficiency
2016	NIHR Health Technology Assessment programme	A programme of studies including assessment of diagnostic accuracy of school hearing screening tests and a cost-effectiveness model of school entry hearing screening programmes
2016	Health Sciences Institute in Aragon (IACS)	Effectiveness, security and economic evaluation of the screening for cryptorchidism
2016	NIHR Health Technology Assessment programme	The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
2016	NIHR Health Technology Assessment programme	An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness
2016	Basque Office for Health Technology Assessment (OSTEBA)	[Impact of the implementation of a population-based cervical cancer screening program based on European recommendations (test/interval) with regard to the current situation]
2016	NIHR Health Technology Assessment programme	A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Neonatal screening: new recommendations
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Assessment on nucleic acid amplification techniques (NAT) for human immunodeficiency, hepatitis C and hepatitis B virus screening in blood banks]
2015	NIHR Health Technology Assessment programme	The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: Beta-kethiolase deficiency (BKT); 3-Hydroxy-3-methyl glutaric aciduria (HMG)]
2015	NIHR Health Technology Assessment programme	A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol
2015	NIHR Health Technology Assessment programme	Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials)